MiMedx (MDXG) COO Ricci Whitlow receives new stock and option awards

Rhea-AI Filing Summary

MIMEDX GROUP, INC. Chief Operating Officer Ricci S. Whitlow reported equity awards on March 4, 2026. She acquired 62,068 stock options and 74,163 shares of restricted common stock at a price of $0.00 per share as compensation grants.

The restricted stock vests fully on the third anniversary of the grant, subject to continued employment. The options vest in four equal annual installments, each 25% on the grant-date anniversaries, also conditioned on continued employment. Following these grants, she directly holds 169,309 stock options and 462,825 common shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Whitlow Ricci S

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Options	62,068	$0.00	--
Grant/Award	Common Stock	74,163	$0.00	--

Holdings After Transaction: Stock Options — 169,309 shares (Direct); Common Stock — 462,825 shares (Direct)

Footnotes (1)

1. Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Whitlow Ricci S

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT NE

(Street)

MARIETTA GA 30062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		A		74,163(1)	A	$0	462,825	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$5.1	03/04/2026		A		62,068		(2)	03/03/2033	Common Stock	62,068	$0	169,309	D

Explanation of Responses:

1. Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

2. The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.

Remarks:

	/s/ William F. Hulse, as attorney-in-fact for Ricci S. Whitlow	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MIMEDX (MDXG) report for Ricci S. Whitlow?

Ricci S. Whitlow, Chief Operating Officer of MIMEDX, reported equity awards on March 4, 2026. She received 62,068 stock options and 74,163 restricted common shares as compensation grants, all at a grant price of $0.00 per share.

How many MIMEDX (MDXG) stock options were granted to the COO?

The Chief Operating Officer of MIMEDX, Ricci S. Whitlow, was granted 62,068 stock options on March 4, 2026. These options were awarded at $0.00 per share as part of her compensation and vest over time, subject to continued employment.

What are the vesting terms for Ricci S. Whitlow’s restricted MIMEDX shares?

The 74,163 restricted common shares granted to Ricci S. Whitlow fully vest on the third anniversary of the March 4, 2026 grant date. Vesting is conditioned on her continued employment under the Restricted Stock Unit Agreement terms.

How do the stock options granted to the MIMEDX COO vest?

The 62,068 stock options granted to Ricci S. Whitlow vest in four equal installments. 25% of the options vest on each anniversary of the March 4, 2026 grant date, contingent on her continued employment under the Nonqualified Stock Option Agreement.

What is Ricci S. Whitlow’s MIMEDX share ownership after these grants?

After the March 4, 2026 awards, Ricci S. Whitlow directly owns 462,825 shares of MIMEDX common stock and 169,309 stock options. These figures reflect her holdings immediately following the reported compensation-related equity grants.

Were Ricci S. Whitlow’s MIMEDX equity awards open-market purchases or compensation grants?

The transactions were compensation grants, not open-market buys. Both the stock options and restricted shares were reported with code A as “Grant, award, or other acquisition” at $0.00 per share, reflecting incentive-based awards tied to employment.